The Clinical Centre of Niš is a medical centre located in Niš, Serbia. It serves as the main medical centre for both Niš and Southern and Southeastern Serbia.

There are 1,525 (2017) beds in Klinički Centar Niš, Klinika za onkologiju.

During the past decade, Klinički Centar Niš, Klinika za onkologiju conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinički Centar Niš, Klinika za onkologiju" are "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Primary Peritoneal Cancer" (1 trials). Many other conditions were trialed in "Klinički Centar Niš, Klinika za onkologiju" in a lesser frequency.

Most popular intervention types in "Klinički Centar Niš, Klinika za onkologiju" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CF102" (1 trials), "Paclical®" (1 trials), "Placebo" (1 trials) and "Taxol®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinički Centar Niš, Klinika za onkologiju" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinički Centar Niš, Klinika za onkologiju". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinički Centar Niš, Klinika za onkologiju, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinički Centar Niš, Klinika za onkologiju, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".